Serum Hepcidin and Iron Absorption in Paediatric Inflammatory Bowel Disease

Autor: Francesca Rossi, Natascia Campostrini, A. Alessandrella, Silverio Perrotta, Renata Auricchio, Annamaria Staiano, Bruno Nobili, Massimo Martinelli, Caterina Strisciuglio, Erasmo Miele, Domenico Girelli
Přispěvatelé: Martinelli, Massimo, Strisciuglio, Caterina, Alessandrella, Annalisa, Rossi, Francesca, Auricchio, Renata, Campostrini, Natascia, Girelli, Domenico, Nobili, Bruno, Staiano, Annamaria, Perrotta, Silverio, Miele, Erasmo
Rok vydání: 2016
Předmět:
Male
medicine.medical_specialty
hepcidin
IBD
Iron Absorption

Iron Absorption
Adolescent
Iron
IBD
Severity of Illness Index
Gastroenterology
Inflammatory bowel disease
03 medical and health sciences
0302 clinical medicine
Crohn Disease
Hepcidins
Hepcidin
Internal medicine
Humans
Medicine
Prospective Studies
Child
Prospective cohort study
Anemia
Iron-Deficiency

biology
medicine.diagnostic_test
business.industry
Case-control study
General Medicine
medicine.disease
Ferritin
Celiac Disease
Cross-Sectional Studies
Logistic Models
Case-Control Studies
Child
Preschool

030220 oncology & carcinogenesis
Erythrocyte sedimentation rate
Ferritins
Immunology
biology.protein
Erythropoiesis
Original Article
Colitis
Ulcerative

Female
030211 gastroenterology & hepatology
hepcidin
Calprotectin
business
Biomarkers
Zdroj: Journal of Crohn's and Colitis. 10:566-574
ISSN: 1876-4479
1873-9946
Popis: We sought to correlate hepcidin levels in inflammatory bowel disease [IBD] children with disease activity, inflammatory markers, and iron load test [ILT] and to compare IBD patients with coeliac and healthy patients.Between December 2012 and June 2013, 145 subjects [50 IBD patients, 45 coeliac patients and 50 healthy controls] were included in the study. All patients underwent the following examinations: blood count, iron status, erythropoiesis parameters, serum hepcidin, C-reactive protein [CRP], and erythrocyte sedimentation rate [ESR]. In order to evaluate the efficacy of iron absorption, ILT was performed in IBD patients. Disease activity indexes and IBD duration, localisation, and therapy were also evaluated, and a faecal sample for calprotectin collected.Serum hepcidin was significantly higher in IBD patients with active disease compared with both coeliac and healthy patients [p = 0.005, p = 0.003 respectively]. In a multivariate logistic regression model, having a Paediatric Crohn's Disease Activity Index [PCDAI] / Paediatric Ulcerative Colitis Activity Index [PUCAI] ≥ 30 resulted in the only variable independently associated with a positive serum hepcidin (odds ratio [OR] = 6.87; 95% confidence interval [CI] 1.4-33, p = 0.01]]. Patients with iron malabsorption [IM] showed higher values of ESR, CRP, and hepcidin [p = 0.02, p = 0.001, and p = 0.06, respectively]. Eight out of 12 [66.7%] children with IM showed an active disease compared with 6/31 [19.3%] children with normal ILT [p = 0.01]. Hepcidin levels correlated negatively with ILT [r = -0.451, p = 0.002], and positively with ferritin and CRP [r = 0.442, p = 0.0001; r = 0.243, p = 0.009, respectively]Our study demonstrates that serum hepcidin is increased in IBD children with active disease and it is responsible for IM.
Databáze: OpenAIRE